We retrospectively analyzed the reasons for ineffective pain relief in patients with idiopathic trigeminal neuralgia (TN) who had undergone pulsed radiofrequency (PRF) treatment guided by computed tomography scan. We found that intraoperative PRF output voltage and electrical field intensity was significantly higher (p < 0.05) in the group who had received effective treatment than in the ineffective group. These findings suggest that optimizing PRF parameters and increasing the intraoperative output voltage (electric field intensity) may therefore, provide better pain relief in patients with TN.
BackgroundBehcet's disease is a kind of systemic vasculitis. Multiple organs including derma, mucosae, articulation, neurologic system, gastrointestinal tract and cardiovascular system might be involved. Vital organ complications lead to poor outcomes. Cardiovascular involvement in Behcet's disease is estimated to range from 7% to 40%, with fatality rate reaches up to 29% [1–3].The characteristics of Chinese Behcet's disease patients with cardiovascular lesions were rarely reported before.ObjectivesTo investigate the clinical characteristics of cardiovascular involvement in Behcet's disease.MethodsWe reviewed 35 medical records of patients of Behcet's disease with cardiovascular lesions in Anzhen Hospital, Capital Medical University between January 2002 and January 2014. All the patients fulfilled the international Behcet's disease study group criteria [4].Results(1) The mean (±SD) age when the cardiovascular disorders flare-up was 36.9±9.6 years. 27/35 (77.1%) of the patients were male.(2) The clinical spectrum of cardiovascular abnormalities included valvular regurgitation (20,57.1%, among these patients, two patients complicated with infectious endocarditis, and five patients had perivalvular leakage after primary valvular surgery), conduction system disturbances (10,28.6%), intracardiac thrombosis (1,2.9%), aneurysms of the arteries (13,37.1%), artery stenosis or occlusion (5,14.3%), pulmonary vascular diseases (3,8.6%), venous thrombosis (4,11.4%). 20 patients had more than one of these lesions simultaneously.(3) Clinical manifestations were varied from shortness of breath (17,48.6%), febrile (9,25.7%), chest pain (5,14.3%), dizziness (4,11.4%), cough (4,11.4%), limb ischemia (4,11.4%), palpitation (3,8.6%), hemoptysis (3,8.6%), seroperitoneum (2,5.7%), facial edema (1,2.9%), dysphagia (1,2.9%), to asymmetric blood pressure (1,2.9%).(4) Inflammatory indicators erythrocyte sedimentation rate and C-reactive protein were not significantly different between the different subgroups (P=0.26 and P=0.972, respectively).(5) Ten patients received corticosteroids and immunosuppressive drugs treatment. Intervention therapy (aortic coated stent lumen isolation) was administered on one patient. Operations (including valve replacement, valular annulus reconstruction, Bentall, aorta replacement and heart transplantation) were performed on 12 patients. One patient (2.9%) died from multiple organ dysfunction during hospital stay.ConclusionsCardiovascular involvement in Behcet's disease is a serious systemic lesion deserved attention. Corticosteroids and immunosuppressive drugs together with intervention therapy or operations are effective remedies for Behcet's disease patients with cardiovascular lesions.ReferencesKajiya T, Anan R, Kameko M, et al. Intracardiac thrombus, superior vena esva syndrome, and pulmonary embolism in a patient with Behcet's disease: a case report and literature review[J]. Heart Vessels, 2007, 22(4):278–283.Geri G, Wechsler B, Thi Huong du L, et al. Spectrum of cardiac Iesions in Behcet disease: a serie...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.